type 2 diabetes glp 1 GLP-1 receptor agonists are increasingly used to treat and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Novel GLP-1–Based Medications for Type

Clinical evidence shows that consistent weekly dosing produces steady-state hormone activation, which optimizes your body's response to lower caloric intake

What should payers do instead

By acting like a natural hormone produced in the gut, these medications address the biological root causes of weight gain

Dairy products, such as high-protein yogurts may also benefit, particularly given the gut benefit of probiotics that are naturally found in yogurts and cultured dairy products

What You'll Discover: How GLP-1 medications drive weight loss in the first place

Animal studies have shown potential risks to fetal development, and human data remain limited